A Review on Current Status of SARS-CoV-2 (2019-nCoV): Its Diagnosis and Challenges

Authors

  • Bhagat Singh Department of Medical Lab. Technology, U P University of Medical Sciences, Saifai Etawah-206130, India.
  • Dheer Singh Department of Anaesthesiology and Critical Care, U P University of Medical Sciences, Saifai, Etawah-206130, India.
  • Kamal Pant Department of Optometry, U P University of Medical Sciences, Saifai, Etawah -206130, India.
  • Ramakant Yadav Department of Neurology, UP University of Medical Sciences, Saifai, Etawah-206130, India.
  • Raj Kumar Department of Neurosurgery, U P University of Medical Sciences, Saifai, Etawah -206130, India.
  • Rajesh Verma Department of Microbiology, U P University of Medical Sciences, Saifai, Etawah-206130, India.
  • Renu Singh Former Visiting Faculty, Microbiology, Faculty of Paramedical Sciences, UPUMS, Saifai, Etawah -206130, India.
  • Satender Saraswat Department of Microbiology, U P University of Medical Sciences, Saifai, Etawah-206130, India.

DOI:

https://doi.org/10.9734/bpi/hmms/v14/9674D

Keywords:

SARS-CoV-2, COVID-19 morphology, clinical manifestation, diagnosis, vaccine development and tear fluid

Abstract

The worldwide pandemic of Covid-19 is a major source of concern because it has an impact on everyone's life, whether directly or indirectly. As a result, inter-personal and social interactions have changed significantly. Up to 19th April 2021, there have been 140,886,773 confirmed cases of COVID-19, including 3,012,251 deaths as reported to World Health Organisation (W.H.O.), out of total confirmed cases only America shares 59,757,984 cases and India 15,061,919 cases. A total of 792,796,083 vaccine doses have been administered globally till 18th April 2021. Repeated emergence and global transmission, large numbers of infected people, infection and mortality among Health Care Workers (HCWs), and increased risk in vulnerable/susceptible groups have all been major sources of concern. We have summarized all the updated information on SARS-CoV-2 (2019-nCoV) including epidemiology, clinical manifestation, laboratory diagnosis, vaccine development, preventive measures and present as well as future challenges.

Published

2021-07-20

How to Cite

Bhagat Singh, Dheer Singh, Kamal Pant, Ramakant Yadav, Raj Kumar, Rajesh Verma, … Satender Saraswat. (2021). A Review on Current Status of SARS-CoV-2 (2019-nCoV): Its Diagnosis and Challenges. Highlights on Medicine and Medical Science Vol. 14, 142–158. https://doi.org/10.9734/bpi/hmms/v14/9674D

Issue

Highlights on Medicine and Medical Science Vol. 14

Section

Chapters